M Kraus & Company Has Trimmed Stake in Cvs Health Corp. (CVS) by $482,274 as Market Valuation Declined; Kames Capital Plc Decreased Position in Kar Auction Services (KAR) by $13.09 Million

February 15, 2018 - By Nellie Frank

Kames Capital Plc decreased its stake in Kar Auction Services Inc. (KAR) by 30.52% based on its latest 2017Q3 regulatory filing with the SEC. Kames Capital Plc sold 278,459 shares as the company’s stock declined 7.64% while stock markets rallied. The institutional investor held 633,958 shares of the consumer durables company at the end of 2017Q3, valued at $30.25M, down from 912,417 at the end of the previous reported quarter. Kames Capital Plc who had been investing in Kar Auction Services Inc. for a number of months, seems to be less bullish one the $6.92 billion market cap company. The stock increased 0.94% or $0.47 during the last trading session, reaching $51.12. About 1.13 million shares traded or 47.54% up from the average. KAR Auction Services, Inc. (NYSE:KAR) has risen 7.49% since February 15, 2017 and is uptrending. It has underperformed by 9.21% the S&P500.

M Kraus & Company decreased its stake in Cvs Health Corp. (CVS) by 21.01% based on its latest 2017Q3 regulatory filing with the SEC. M Kraus & Company sold 5,954 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 22,384 shares of the medical and nursing services company at the end of 2017Q3, valued at $1.82 million, down from 28,338 at the end of the previous reported quarter. M Kraus & Company who had been investing in Cvs Health Corp. for a number of months, seems to be less bullish one the $70.92B market cap company. The stock increased 0.31% or $0.21 during the last trading session, reaching $70. About 2.91 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 15, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It fall, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Millennium Mngmt Ltd Co reported 0.03% in CVS Health Corporation (NYSE:CVS). Sei Invests accumulated 507,325 shares. Vaughan David Invs Il holds 217,880 shares or 0.87% of its portfolio. Rhumbline Advisers accumulated 0.33% or 1.88M shares. Amp Cap Investors Ltd owns 483,705 shares. Perella Weinberg Cap Mgmt Lp stated it has 73,268 shares. Harvest Management Inc holds 3,070 shares. Eads & Heald Invest Counsel accumulated 16,708 shares. Pring Turner Cap Group Incorporated Incorporated reported 32,650 shares stake. World Asset Mngmt holds 0.27% or 98,604 shares. Systematic Fin Management Lp stated it has 0.04% in CVS Health Corporation (NYSE:CVS). Boltwood Capital stated it has 0.45% in CVS Health Corporation (NYSE:CVS). 23,610 are owned by Tctc Hldgs Ltd Liability Com. Moreover, Ariel Invests Limited Liability Co has 0.11% invested in CVS Health Corporation (NYSE:CVS). 1.75 million were accumulated by Eaton Vance Mgmt.

Since August 16, 2017, it had 0 buys, and 6 sales for $58.12 million activity. Foulkes Helena had sold 39,340 shares worth $3.22 million. The insider Roberts Jonathan C sold $7.13M. SWIFT RICHARD J also sold $199,050 worth of CVS Health Corporation (NYSE:CVS) on Wednesday, August 16. Another trade for 90,267 shares valued at $7.19M was made by Moriarty Thomas M on Monday, September 11. Denton David M sold $18.88M worth of CVS Health Corporation (NYSE:CVS) on Monday, September 11.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 72 analyst reports since July 22, 2015 according to SRatingsIntel. Oppenheimer maintained the shares of CVS in report on Monday, November 2 with “Outperform” rating. The company was maintained on Thursday, May 12 by Jefferies. The firm has “Buy” rating by Vetr given on Monday, August 24. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Needham on Friday, September 8. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, June 20. SunTrust maintained the shares of CVS in report on Thursday, January 4 with “Buy” rating. As per Friday, January 5, the company rating was upgraded by Morgan Stanley. Tigress Financial initiated the shares of CVS in report on Friday, April 28 with “Buy” rating. The rating was maintained by Tigress Financial with “Buy” on Tuesday, December 26. On Tuesday, January 30 the stock rating was upgraded by Needham to “Buy”.

Among 9 analysts covering KAR Auction Services (NYSE:KAR), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. KAR Auction Services had 24 analyst reports since July 24, 2015 according to SRatingsIntel. JP Morgan maintained the stock with “Overweight” rating in Monday, October 30 report. The firm earned “Buy” rating on Wednesday, June 14 by Jefferies. The stock of KAR Auction Services, Inc. (NYSE:KAR) earned “Buy” rating by Sterne Agee CRT on Monday, May 2. The firm has “Hold” rating by Zacks given on Thursday, August 27. Robert W. Baird maintained KAR Auction Services, Inc. (NYSE:KAR) on Tuesday, October 3 with “Buy” rating. The stock has “Hold” rating by Stephens on Tuesday, January 16. The stock has “Neutral” rating by Goldman Sachs on Friday, February 12. Zacks upgraded KAR Auction Services, Inc. (NYSE:KAR) on Friday, August 21 to “Hold” rating. The firm has “Buy” rating by Jefferies given on Monday, September 11. The stock of KAR Auction Services, Inc. (NYSE:KAR) earned “Buy” rating by Jefferies on Wednesday, July 19.

Analysts await KAR Auction Services, Inc. (NYSE:KAR) to report earnings on February, 20. They expect $0.52 EPS, up 15.56% or $0.07 from last year’s $0.45 per share. KAR’s profit will be $70.34M for 24.58 P/E if the $0.52 EPS becomes a reality. After $0.57 actual EPS reported by KAR Auction Services, Inc. for the previous quarter, Wall Street now forecasts -8.77% negative EPS growth.

Kames Capital Plc, which manages about $3.65 billion US Long portfolio, upped its stake in Watsco Inc. (NYSE:WSO) by 30,209 shares to 126,913 shares, valued at $20.44M in 2017Q3, according to the filing. It also increased its holding in The Clorox Company (NYSE:CLX) by 111,241 shares in the quarter, for a total of 451,699 shares, and has risen its stake in Activision Blizzard Inc. (NASDAQ:ATVI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Nellie Frank

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts